(PharmaNewsWire.Com, October 19, 2019 ) The global Reaction Monitoring market is segmented on the basis of technology, reaction mode, and end user and region. Growth in female geriatric population and rising incidence of gynecological diseases, the increasing adoption of minimally invasive treatments, increasing adoption of office hysteroscopy, and technological advancements are the major factors driving the growth of this market.
On the basis of technology, the market is categorized into spectroscopy, chromatography, X-ray diffraction, calorimetry, and titrimetry. In 2017, the spectroscopy segment is expected to account for the largest share of the market. The large share of this segment can be attributed to the widespread use of spectroscopic techniques, increasing drug development pipelines, and stringent regulatory compliance for drug manufacturing & food processing protocols.
Based on reaction mode, the market is segmented into qualitative reaction mode and quantitative reaction mode. The quantitative reaction mode segment is estimated to command the largest share of the global market in 2017. The large share of this segment is mainly due to factors such as ongoing technological advancements in the field of analytical techniques (such as real-time quantification, device miniaturization, and process automation) and ongoing expansion and modernization of the pharmaceutical & biotechnology and food processing industries.
On the basis of end user, the market is segmented pharmaceutical, biopharmaceutical, and biotechnology companies, life science and genomic research facilities, food and beverage industry, pollution monitoring and control industry, and other end users. The pharmaceutical, biopharmaceutical, and biotechnology companies segment is projected to register the fastest rate during the forecast period. This can be attributed to the stringent regulations for pharmaceutical drug development and manufacturing (such as cGMP, cGLP, and EXCiPACT certification) and increasing usage of analytical techniques during quality assessment during drug manufacturing.
Geographically, the reaction monitoring market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global reaction monitoring market in 2017. The growth of this region is attributed to the availability of private-public funding & investments for life science research, stringent regulatory framework for drug development & commercialization, effective implementation & industrial compliance with food safety regulations, rising adoption of technologically advanced pollution monitoring & control products, and growing number of clinical researches in this region.
The major players in the market are Agilent (US), Danaher (US), PerkinElmer (US), Shimadzu (Japan), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Bruker (US), Waters (US), Hitachi High-Technologies (Japan), Merck (Germany), ABB (Switzerland), Mettler-Toledo International (US) , and HORIBA (Japan).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
